Alternating carboplatin and doxorubicin as adjunctive chemotherapy to amputation or limb-sparing surgery in the treatment of appendicular osteosarcoma in dogs

Journal of Veterinary Internal Medicine

Volumn 18, Issue 4, 2004, Pages 540-544

  Kent, Michael S ^a   Strom, Adam ^a   London, Cheryl A ^a   Seguin, Bernard ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; Canine; Neoplasia; Primary bone tumor

Indexed keywords

CARBOPLATIN; DOXORUBICIN;

AMPUTATION; ANOREXIA; ARTICLE; CANCER ADJUVANT THERAPY; CONTROLLED STUDY; DIARRHEA; DOG DISEASE; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVITY; FEMALE; GASTROINTESTINAL TOXICITY; MALE; NEUTROPENIA; NONHUMAN; OSTEOSARCOMA; PROGNOSIS; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT PLANNING; VOMITING;

AMPUTATION; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CALIFORNIA; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; DOG DISEASES; DOGS; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; EXTREMITIES; FEMALE; INFUSIONS, INTRAVENOUS; MALE; OSTEOSARCOMA; RECORDS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

CANIS FAMILIARIS;

EID: 4243139488     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2004)18<540:ACADAA>2.0.CO;2     Document Type: Article

References (26)

1. Brodey RS, Riser WH. Canine osteosarcoma. A clinicopathologic study of 194 cases. Clin Orthop 1969;62:54-64.
2. Plumlee KH, Haynes JS, Kersting KW, et al. Osteosarcoma in a cow. J Am Vet Med Assoc 1993;202:95-96.
3. Hoover JP, Paulsen DB, Qualls CW, et al. Osteogenic sarcoma with subcutaneous involvement in a rabbit. J Am Vet Med Assoc 1986;189:1156-1158.
4. Bitetto WV, Patnaik AK, Schrader SC, et al. Osteosarcoma in cats: 22 cases (1974-1984). J Am Vet Med Assoc 1987;190:91-93.
5. Heldmann E, Anderson MA, Wagner-Mann C. Feline osteosarcoma: 145 cases (1990-1995). J Am Anim Hosp Assoc 2000;36:518-521.
6. Cooley DM, Waters DJ. Skeletal neoplasms of small dogs: A retrospective study and literature review. J Am Anim Hosp Assoc 1997;33:11-23.
7. Brodey RS, Abt DA. Results of surgical treatment in 65 dogs with osteosarcoma. J Am Vet Med Assoc 1976;168:1032-1035.
8. Spodnick GJ, Berg J, Rand WM, et al. Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988). J Am Vet Med Assoc 1992;200:995-999.
9. Berg J. Canine osteosarcoma: Amputation and chemotherapy. Vet Clin North Am Small Anim Pract 1996;26:111-121.
10. Madewell BR, Leighton RL, Theilen GH. Amputation and doxorubicin for treatment of canine and feline osteogenic sarcoma. Eur J Cancer 1978;14:287-293.
11. Berg J, Weinstein MJ, Springfield DS, et al. Results of surgery and doxorubicin chemotherapy in dogs with osteosarcoma. J Am Vet Med Assoc 1995;206:1555-1560.
12. Shapiro W, Fossum TW, Kitchell BE, et al. Use of cisplatin for treatment of appendicular osteosarcoma in dogs. J Am Vet Med Assoc 1988;192:507-511.
13. Straw RC, Withrow SJ, Richter SL, et al. Amputation and cisplatin for treatment of canine osteosarcoma [published erratum appears in J Vet Intern Med 1992;6(4):205]. J Vet Intern Med 1991;5:205-210.
14. Kraegel SA, Madewell BR, Simonson E, et al. Osteogenic sarcoma and cisplatin chemotherapy in dogs: 16 cases (1986-1989). J Am Vet Med Assoc 1991;199:1057-1059.
15. Thompson JP, Fugent MJ. Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osteosarcoma in dogs: 30 cases (1979-1990). J Am Vet Med Assoc 1992;200:531-533.
16. Berg J, Weinstein MJ, Schelling SH, et al. Treatment of dogs with osteosarcoma by administration of cisplatin after amputation or limb-sparing surgery: 22 cases (1987-1990). J Am Vet Med Assoc 1992;200:2005-2008.
17. Bergman PJ, MacEwen EG, Kurzman ID, et al. Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993). J Vet Intern Med 1996;10:76-81.
18. Mauldin GN, Matus RE, Withrow SJ, et al. Canine osteosarcoma. Treatment by amputation versus amputation and adjuvant chemotherapy using doxorubicin and cisplatin. J Vet Intern Med 1988;2:177-180.
19. Berg J, Gebhardt MC, Rand WM. Effect of timing of postoperative chemotherapy on survival of dogs with osteosarcoma. Cancer 1997;79:1343-1350.
20. Chun R, Kurzman ID, Couto CG, et al. Cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma: A pilot study. J Vet Intern Med 2000;14:495-498.
21. Goldie JH, Coldman AJ, Gudauskas GA. Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treat Rep 1982;66:439-449.
22. Goldie JH, Coldman AJ. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 1979;63:1727-1733.
23. Plumb DC. Veterinary drug handbook, 4th ed. Ames, IA: distributed by Iowa State Press; 2002:960.
24. Kent MS, Madewell BR, Dank G, et al. An anticopper antangiogenic approach for advanced cancer in spontaneously occurring tumors using tetrathiomolybdate: A pilot study in a canine animal model. J Trace Elem Exp Med. In press.
25. Ehrhart N, Dernell WS, Hoffmann WE, et al. Prognostic importance of alkaline phosphatase activity in serum from dogs with appendicular osteosarcoma: 75 cases (1990-1996). J Am Vet Med Assoc 1998;213:1002-1006.
26. Garzotto CK, Berg J, Hoffmann WE, et al. Prognostic significance of serum alkaline phosphatase activity in canine appendicular osteosarcoma. J Vet Intern Med 2000;14:587-592.